Wen-Chin Tsai

Executive Director of Pharmaceutical Development at Polaris Pharmaceuticals - San Diego, CA, US

Wen-Chin Tsai's Colleagues at Polaris Pharmaceuticals
Enrique Miranda

Assistant Manager IT/Facilities Supervisor

Contact Enrique Miranda

Shaw Chen

Executive VP

Contact Shaw Chen

Mark Zhang

Analyst, Software Implementation & Support / Data Management

Contact Mark Zhang

Soneprasith Phonephaly

Scientist

Contact Soneprasith Phonephaly

Nia Hines

Quality Control Analyst

Contact Nia Hines

Mariusz Stempniak

Senior Scientist

Contact Mariusz Stempniak

Andy Shih

Senior Project Coordinator

Contact Andy Shih

View All Wen-Chin Tsai's Colleagues
Wen-Chin Tsai's Contact Details
Email (Verified)
***@polarispharma.com
Get Wen-Chin Tsai's Email Address
Mobile Number
(XXX) XXX-XXXX
Get Wen-Chin Tsai's Mobile Number
HQ
858-452-6688
Location
Company
Polaris Pharmaceuticals
Wen-Chin Tsai's Company Details
Polaris Pharmaceuticals logo, Polaris Pharmaceuticals contact details

Polaris Pharmaceuticals

San Diego, CA, US • 50 - 99 Employees
Major Drugs

Polaris Group, a privately held multinational biopharmaceutical drug company, specializes in the research and development of protein drugs to treat cancer and other debilitating diseases in humans.Polaris' lead project is ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma.Polaris is collaborating with EnzymeRx in the development of Uricase-PEG 20 for the treatment of gout, tumor lysis syndrome, and other diseases related to hyperuricemia.Polaris is also researching and developing other biotherapeutic agents and has a small molecule drug program. The latter utilizes a rational structure-based approach for the design of novel compounds that inhibit the biological function of cancer-related protein targets.

ADI-PEG 20 (Oncology) Uricase-PEG 20 TNF-PEG 20 CK2 inhibitor B2B Major Drugs Pharmaceutical Preparations Pharmaceuticals Biotech Pharmaceuticals
Details about Polaris Pharmaceuticals
Frequently Asked Questions about Wen-Chin Tsai
Wen-Chin Tsai currently works for Polaris Pharmaceuticals.
Wen-Chin Tsai's role at Polaris Pharmaceuticals is Executive Director of Pharmaceutical Development.
Wen-Chin Tsai's email address is ***@polarispharma.com. To view Wen-Chin Tsai's full email address, please signup to ConnectPlex.
Wen-Chin Tsai works in the Pharmaceuticals industry.
Wen-Chin Tsai's colleagues at Polaris Pharmaceuticals are Enrique Miranda, Shaw Chen, Mark Zhang, Soneprasith Phonephaly, Nia Hines, Mariusz Stempniak, Andy Shih and others.
Wen-Chin Tsai's phone number is 858-452-6688
See more information about Wen-Chin Tsai